Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bevan

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Oncogene|December 20, 2011
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgensD A Dart, G N Brooke, A Sita-Lumsden, et al.
Cellular Signalling|August 7, 2010
Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancerVikash Reebye, Charlotte L Bevan, Mahrokh Nohadani, et al.
Archives of Disease in Childhood|June 1, 1997
Phenotypic diversity in siblings with partial androgen insensitivity syndromeB A Evans, I A Hughes, C L Bevan, et al.
Journal of Social and Personal Relationships|April 11, 2024
A descriptive literature review of early research on COVID-19 and close relationshipsJennifer L Bevan, Madison K Murphy, Pamela J Lannutti, et al.
Muscle & Nerve|February 1, 1992
Fatigue-related changes in motor unit action potentials of adult catsR M Enoka, N Trayanova, Y Laouris, et al.
Asian Journal of Urology|August 4, 2020
Coordinated AR and microRNA regulation in prostate cancerIeva Eringyte, Joanna N Zamarbide Losada, Sue M Powell, et al.
The Journal of Biological Chemistry|October 9, 2002
Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional controlValerie Christiaens, Charlotte L Bevan, Leen Callewaert, et al.
Frontiers in Oncology|September 13, 2024
Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growthFoteini Kalofonou, Damien A Leach, Sue M Powell, et al.
The Journal of Biological Chemistry|April 2, 2011
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectorsDerek N Lavery, M Angeles Villaronga, Marjorie M Walker, et al.
Nature Reviews. Clinical Oncology|November 13, 2019
Cytoreductive treatment strategies for de novo metastatic prostate cancerMartin J Connor, Taimur T Shah, Gail Horan, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Oncogene|December 20, 2011
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgensD A Dart, G N Brooke, A Sita-Lumsden, et al.
Cellular Signalling|August 7, 2010
Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancerVikash Reebye, Charlotte L Bevan, Mahrokh Nohadani, et al.
Archives of Disease in Childhood|June 1, 1997
Phenotypic diversity in siblings with partial androgen insensitivity syndromeB A Evans, I A Hughes, C L Bevan, et al.
Journal of Social and Personal Relationships|April 11, 2024
A descriptive literature review of early research on COVID-19 and close relationshipsJennifer L Bevan, Madison K Murphy, Pamela J Lannutti, et al.
Muscle & Nerve|February 1, 1992
Fatigue-related changes in motor unit action potentials of adult catsR M Enoka, N Trayanova, Y Laouris, et al.
Asian Journal of Urology|August 4, 2020
Coordinated AR and microRNA regulation in prostate cancerIeva Eringyte, Joanna N Zamarbide Losada, Sue M Powell, et al.
The Journal of Biological Chemistry|October 9, 2002
Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional controlValerie Christiaens, Charlotte L Bevan, Leen Callewaert, et al.
Frontiers in Oncology|September 13, 2024
Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growthFoteini Kalofonou, Damien A Leach, Sue M Powell, et al.
The Journal of Biological Chemistry|April 2, 2011
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectorsDerek N Lavery, M Angeles Villaronga, Marjorie M Walker, et al.
Nature Reviews. Clinical Oncology|November 13, 2019
Cytoreductive treatment strategies for de novo metastatic prostate cancerMartin J Connor, Taimur T Shah, Gail Horan, et al.
Pageof 14